TF and cancer: We next evaluated the lower limit of detection (LLOD) for MRD-EDGESNV with in silico TF admixtures (melanoma plasma WGS mixed into plasma WGS from an individual with no known cancer; see Methods for in silico admixtures detail; Fig. 1e, Supplementary Table 4).